European Access Academy
A multi-stakeholder initiative aiming to facilitate and support the development of a joint European value framework for the assessment of innovative health technologies
The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.
The
EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's HTA Stakeholder Network.
EAA News & Media Posts
November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on Joint Scientific Consultations for Medical Devices
Building on the recently introduced EU Regulations on Medical Devices (2017/745; MDR) and on In Vitro Diagnostic Medical Devices (2017/746; IVDR), the EU HTAR introduces specific comparative evidence requirements for certain class IIb and class III devices. Considering the crucial role of joint scientific consultations in the HTA process overall, but especially to medical device manufacturers (lacking extensive experience with HTA procedures so far) the EAA Faculty provided feedback on the Draft Implementing Act on Joint Scientific Consultations for Medical Devices.
October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC
June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI
June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain
April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons
April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA
Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'
Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA
Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts
THANK YOU for joining the
EAA Fall Convention 2024
'EU HTA: Transitioning from Preparation to Implementation - Approaching the Pain Points'
We had excellent, heated and very fruitful and constructive discusssions with our expert panel (including Marco Marchetti, Robert Giovanni Nisticò, Elias Pèan, Robin Doeswijk, François Houÿez, Bernhard Wörmann, Nathalie Largeron), the Italian Oganising Committee (Fabrizio Gianfrate, Renato Bernardini, Stefano Capri) and all our virtual and on-site participants.
Many thanks to all who contributed!
We look forward to continuing the dialogue after the implementation of the EU HTAR:
Save the Date of our Spring Convention 2025 in Berlin
(April 3rd).
NOW AVAILABLE:
Video Recordings of all impulse presentations are available HERE
and the EAA Convention Proceedings Issue #6
(click image to download the pdf)
The EAA is an initiative hosted by Copenhagen University, Utrecht University, Vlerick Business School, Agència de Qualitat I Avaluació Sanitàries de Catalunya, Erasmus University, LUISS Business School and endorsed & funded by:
Springer Healthcare, Abbvie, AstraZeneca, Bayer, Novartis, Pfizer, Roche, Sanofi , vfa, leem and efpia.